IGF axis gene expression patterns are prognostic of survival in epithelial ovarian cancer

Endocrine-Related Cancer

Volumn 14, Issue 3, 2007, Pages 781-790

  Spentzos, Dimitrios ^a   Cannistra, Stephen A ^a   Grall, Franck ^a   Levine, Douglas A ^b   Pillay, Kamana ^a   Libermann, Towia A ^a   Mantzoros, Christos S ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 4;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; GENOMICS; HUMAN; HUMAN TISSUE; KOLMOGOROV SMIRNOV TEST; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; MUTATION; OUTCOME ASSESSMENT; OVARY CANCER; PROGNOSIS; SIGNAL TRANSDUCTION; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LINKAGE (GENETICS); MIDDLE AGED; MODELS, BIOLOGICAL; MULTIGENE FAMILY; MULTIVARIATE ANALYSIS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; PROGNOSIS; SIGNAL TRANSDUCTION; SOMATOMEDINS; SURVIVAL ANALYSIS;

EID: 35948983048     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/ERC-06-0073     Document Type: Article

References (46)

1. Cannistra SA 2004 Cancer of the ovary. New England Journal of Medicine 351 2519-2529.
2. Chakrabarty S & Kondratick L 2006 Insulin-like growth factor binding protein-2 stimulates proliferation and activates multiple cascades of the mitogen-activated protein kinase pathways in NIH-OVCAR3 human epithelial ovarian cancer cells. Cancer Biology and Theraphy 5 189-197.
3. Chan JM, Stampfer MJ, Giovannucci E, Ma J & Pollak M 2000 Insulin-like growth factor I (IGF-I), IGF-binding protein-3 and prostate cancer risk: epidemiological studies. Growth Hormone and IGF Research 10 S32-S33.
4. Conover CA, Hartmann LC, Bradley S, Stalboerger P, Klee GG, Kalli KR & Jenkins RB 1998 Biological characterization of human epithelial ovarian carcinoma cells in primary culture: the insulin-like growth factor system. Experimental Cell Research 238 439-449.
5. Eisen MB, Spellman PT, Brown PO & Botstein D 1998 Cluster analysis and display of genome-wide expression patterns. PNAS 95 14863-14868.
6. Giovannucci E, Pollak MN, Platz EA, Willett WC, Stampfer MJ, Majeed N, Colditz GA, Speizer FE & Hankinson SE 2000 A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiology, Biomarkers and Prevention 9 345-349.
7. Gotlieb WH, Bruchim I, Gu J, Shi Y, Camirand A, Blouin MJ, Zhao Y & Pollak MN 2006 Insulin-like growth factor receptor I targeting in epithelial ovarian cancer. Gynecologic Oncology 100 389-396.
8. Gu X, Zerbini LF, Otu HH, Bhasin M, Yang Q, Joseph MG, Grail F, Onatunde T, Correa RG & Libermann TA 2007 Reduced PDEF, expression increases invasion and expression of mesenchymal genes in prostate cancer cells. Cancer Research 67 4219-4226.
9. Guilherme A & Czech MP 1998 Stimulation of IRS-1-associated phosphatidylinositol 3-kinase and Akt/protein kinase B but not glucose transport by beta1-integrin signaling in rat adipocytes. Journal of Biological Chemistry 273 33119-33122.
10. Hankinson SE & Schernhammer ES 2003 Insulin-like growth factor and breast cancer risk: evidence from observational studies. Breast Disease 17 27-40.
11. Hosack DA, Dennis G Jr, Sherman BT, Lane HC & Lempicki RA 2003 Identifying biological themes within lists of genes with EASE. Genome Biology 4 R70.
12. Jazaeri AA, Awtrey CS, Chandramouli GV, Chuang YE, Khan J, Sotiriou C, Aprelikova O, Yee CJ, Zorn KK, Birrer MJ et al. 2005 Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers. Clinical Cancer Research 11 6300-6310.
13. Kalli KR & Conover CA 2003 The insulin-like growth factor/insulin system in epithelial ovarian cancer. Frontiers in Bioscience 8 d714-d722.
14. Kalli KR, Falowo OI, Bale LK, Zschunke MA, Roche PC & Conover CA 2002 Functional insulin receptors on human epithelial ovarian carcinoma cells: implications for IGF-II mitogenic signaling. Endocrinology 143 3259-3267.
15. Krueckl SL, Sikes RA, Edlund NM, Bell RH, Hurtado-Coll A, Fazli L, Gleave ME & Cox ME 2004 Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression model. Cancer Research 64 8620-8629.
16. Lamb J, Ramaswamy S, Ford HL, Contreras B, Martinez RV, Kittrell FS, Zahnow CA, Patterson N, Golub TR & Ewen ME 2003 A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114 323-334.
17. Lebrun P, Baron V, Hauck CR, Schlaepfer DD & Van Obberghen E 2000 Cell adhesion and focal adhesion kinase regulate insulin receptor substrate-1 expression. Journal of Biological Chemistry 275 38371-38377.
18. LeRoith D & Roberts CT Jr 2003 The insulin-like growth factor system and cancer. Cancer Letters 195 127-137.
19. LeRoith D, Werner H, Beitner-Johnson D & Roberts CT Jr 1995 Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocrine Reviews 16 143-163.
20. Li C & Wong WH 2001a Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. PNAS 98 31-36.
21. Li C & Wong WH 2001b Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application. Genome Biology 2. RESEARCH0032.
22. Lukanova A, Lundin E, Toniolo P, Micheli A, Akhmedkhanov A, Rinaldi S, Muti P, Lenner P, Biessy C, Krogh V et al. 2002 Circulating levels of insulin-like growth factor-I and risk of ovarian cancer. International Journal of Cancer 101 549-554.
23. Mantzoros CS, Tzonou A, Signorello LB, Stampfer M, Trichopoulos D & Adami HO 1997 Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. British Journal of Cancer 76 1115-1118.
24. Dal Maso L, Augustin LS, Franceschi S, Talamini R, Polesel J, Kendall CW, Jenkins DJ, Vidgen E & La Vecchia C 2004 Association between components of the insulin-like growth factor system and epithelial ovarian cancer risk. Oncology 67 225-230.
25. Min Y, Adachi Y, Yamamoto H, Imsumran A, Arimura Y, Endo T, Hinoda Y, Lee CT, Nadaf S, Carbone DP et al. 2005 Insulin-like growth factor I receptor blockade enhances chemotherapy and radiation responses and inhibits tumour growth in human gastric cancer xenografts. Gut 54 591-600.
26. Mitsiades CS & Mitsiades N 2005 Treatment of hematologic malignancies and solid tumors by inhibiting IGF receptor signaling. Expert Review of Anticancer Therapy 5 487-499.
27. Mitsiades CS, Mitsiades NS, McMullan CJ, Poulaki V, Shringarpure R, Akiyama M, Hideshima T, Chauhan D, Joseph M, Libermann TA et al. 2004 Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors. Cancer Cell 5 221-230.
28. Moschos SJ & Mantzoros CS 2002 The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology 63 317-332.
29. O'Dell SD & Day IN 1998 Insulin-like growth factor II (IGF-II). International Journal of Biochemistry and Cell Biology 30 767-771.
30. Pavlidis P, Lewis DP & Noble WS 2002 Exploring gene expression data with class scores. Pacific Symposium on Biocomputing 7 474-485.
31. Perks CM, Bowen S, Gill ZP, Newcomb PV & Holly JM 1999 Differential IGF-independent effects of insulin-like growth factor binding proteins (1-6) on apoptosis of breast epithelial cells. Journal of Cellular Biochemistry 75 652-664.
32. Pollak MN, Schernhammer ES & Hankinson SE 2004 Insulin-like growth factors and neoplasia. Nature Review Cancer 4 505-518.
33. Pricci F, Pugliese G, Romano G, Romeo G, Locuratolo N, Pugliese F, Mene P, Galli G, Casini A, Rotella CM et al. 1996 Insulin-like growth factors I and II stimulate extracellular matrix production in human glomerular mesangial cells, comparison with transforming growth factor-beta. Endocrinology 137 879-885.
34. Ravid D, Maor S, Werner H & Liscovitch M 2005 Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling. Oncogene 24 1338-1347.
35. Resnicoff M, Abraham D, Yutanawiboonchai W, Rotman HL, Kajstura J, Rubin R, Zoltick P & Baserga R 1995 The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Research 55 2463-2469.
36. Sayer RA, Lancaster JM, Pittman J, Gray J, Whitaker R, Marks JR & Berchuck A 2005 High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer. Gynecologic Oncology 96 355-361.
37. Spentzos D, Levine DA, Ramoni MF, Joseph M, Gu X, Boyd J, Libermann TA & Cannistra SA 2004 Gene expression signature with independent prognostic significance in epithelial ovarian cancer. Journal of Clinical Oncology 22 4700-4710.
38. Spentzos D, Levine DA, Kolia S, Otu H, Boyd J, Libermann TA & Cannistra SA 2005 Unique gene expression profile based on pathologic response in epithelial ovarian cancer. Journal of Clinical Oncology 23 7911-7918.
39. Stewart CE & Rotwein P 1996 Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiological Reviews 76 1005-1026.
40. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES et al. 2005 Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. PNAS 102 15545-15550.
41. Tang Y, Zhang D, Fallavollita L & Brodt P 2003 Vascular endothelial growth factor C expression and lymph node metastasis are regulated by the type I insulin-like growth factor receptor. Cancer Research 63 1166-1171.
42. Wright GW & Simon RM 2003 A random variance model for detection of differential gene expression in small microarray experiments. Pacific Symposium on Biocomputing 19 2448-2455.
43. Yee D, Paik S, Lebovic GS, Marcus RR, Favoni RE, Cullen KJ, Lippman ME & Rosen N 1989 Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer. Molecular Endocrinolgy 3 509-517.
44. Zerbini LF, Wang Y, Cho JY & Libermann TA 2003 Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer. Cancer Research 63 2206-2215.
45. Zerbini LF, Wang Y, Czibere A, Correa RG, Cho JY, Ijiri K, Wei W, Joseph M, Gu X, Grail F et al. 2004 NF-kappa B-mediated repression of growth arrest- and DNA-damage-inducible proteins 45alpha and gamma is essential for cancer cell survival. PNAS 101 13618-13623.
46. Zerbini LF, Czibere A, Wang Y, Correa RG, Otu H, Joseph M, Takayasu Y, Silver M, Gu X, Ruchusatsawat K et al. 2006 A novel pathway involving melanoma differentiation associated gene-7/interleukin-24 mediates nonsteroidal anti-inflammatory drug-induced apoptosis and growth arrest of cancer cells. Cancer Research 66 11922-11931.